Get all your news in one place.
100’s of premium titles.
One app.
Start reading
The Canberra Times
The Canberra Times
National
Lanie Tindale

Three more people die with COVID in Canberra

In-depth COVID

Three men in the ACT with COVID-19 have died. One man in his 70s, one in his 80s and another in his 90s.

There were 87 people with COVID-19 in hospital in the 24 hours to Monday 8pm. Of those, one patient was in the ICU but none on ventilation.

That compares with 89 patients in hospital with COVID in the previous report. Two of those were in intensive care but none on ventilation.

The ACT recorded 869 new COVID-19 cases in the 24 hours until 8pm Monday. Of those, 430 were from PCR tests and 439 from rapid antigen tests.

Of the new cases, 228 were in people aged between 25 and 39 years of age.

The ACT's COVID-19 death toll is 78 after a second day in a row with a reported death. A woman in her 80s with COVID-19 was reported as dead on Monday.

New cases by age group

  • 0-4 years: 63
  • 5-11 years: 76
  • 12-17 years: 75
  • 18-24 years: 92
  • 25-39 years: 228
  • 40-49 years: 146
  • 50-64 years: 137
  • 65+ years: 52
  • Total: 869

It was revealed on Friday that five of six reported COVID deaths were from the same aged care facility, Canberra Aged Care in Lyneham.

There was a delay in reporting the May fatalities due to internal delays from the residential aged care facility.

As of May 26, there were 68 resident cases and 35 staff cases at the facility.

Jindalee Aged Care residence had 27 cases among residents, and 19 staff members.

Do you know more?

  • We are looking into the COVID-19 situation in Canberra aged care homes. If you have anything you would like to share, please contact us through this form (you can be anonymous) or email lanie.tindale@canberratimes.com.au.

COVID-19 vaccinations

A new COVID-19 vaccine developed in South Australia and administered with a needle-free device is to begin human trials.

Designed by University of Adelaide researchers the DNA vaccine also targets the Omicron variant of the virus and can be adapted for future variants.

DNA vaccines require simple engineering design modifications that can be made quickly to adapt to new strains.

It is being manufactured in SA at the BioCina facility in Adelaide.

  • Aged 5-11 years (1 dose): 80.6 per cent
  • Aged 5-11 years (2 doses): 68.8 per cent
  • Aged 5+ years (2 doses): 97.3 per cent
  • Aged 16+ years (3 doses): 77.1 per cent

Around Australia

NSW

  • Deaths: 7
  • New cases: 7805
  • Hospitalisations: 1499
  • ICU: 57
  • Ventilation: Unknown

Victoria

  • Deaths: 28
  • New cases: 7507
  • Hospitalisations: 434
  • ICU: 21
  • Ventilation: 9

Queensland

  • Deaths: 4
  • New cases: 4797
  • Hospitalisations: 491
  • ICU: 7
  • Ventilation: Unknown

South Australia

  • TBA

Tasmania

  • Deaths: 0
  • New cases: 1001
  • Hospitalisations: 41
  • ICU: 2
  • Ventilation: Unknown

Western Australia

  • TBA

Northern Territory

  • New cases: 232
  • Hospitalisations: 17
  • ICU: 0
  • Ventilation: 0

More to come. 

Our coverage of the health and safety aspects of this outbreak of COVID-19 in the ACT is free for anyone to access. However, we depend on subscription revenue to support our journalism. If you are able, please subscribe here. If you are already a subscriber, thank you for your support. You can also sign up for our newsletters for regular updates.

CEO of Capital Pathology Jason Gluch. Picture: Dion Georgopoulos
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.